Lannett Co., Inc (LCI)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

9000 STATE RD PHILADELPHIA, PA 19136

Lannett Company and subsidiaries develop, manufacture, package, market, and distribute finished dosage forms of drugs and manufacture active pharmaceutical ingredients. Co. manufactures solid oral dosage forms, including tablets and capsules, topical and oral solutions. All of Co.'s products manufactured and/or sold are prescription products. Co.'s products include those containing Levo, Digoxin tablets, products containing Butalbital, Morphine Sulfate Oral Solution and Cocaine Topical Solution. Co. has several generic products under development. These products are all orally-administered, topical, injectable and parenteral products designed to be generic equivalents to brand named drugs.

Data based on most recent fiscal year report
Market Cap595.66 Million Shares Outstanding37.7 Million Avg Volume1.221 Million
1-Yr BETA vs S&P TR2.033 Current Ratio2.72 Quick Ratio2.09
View SEC Filings from LCI instead.

View recent insider trading info

Funds Holding LCI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LCI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LEPORE PATRICK G

  • Director
300,000 2019-11-15 4

LANDIS G. MICHAEL PRINCIPAL ACCOUNTING OFFICER

  • Officer
37,686 2019-11-12 5

KOZLOWSKI JOHN VP OF FINANCE & CFO

  • Officer
50,459 2019-11-09 6

EHLINGER ROBERT VP AND CIO

  • Officer
47,117 2019-09-30 3

ABT JOHN CHIEF QUALITY AND OPERATIONS

  • Officer
46,312 2019-09-30 3

CREW TIMOTHY C CHIEF EXECUTIVE OFFICER

  • Officer
186,567 2019-09-30 5

PAONESSA ALBERT III

  • Director
45,945 2019-09-09 3

GALVAN MARTIN P FORMER VP OF FINANCE & CFO

  • Officer
102,409 2019-08-30 3

ISRAEL SAMUEL H CHIEF LEGAL OFFICER

  • Officer
68,283 2019-07-29 1

CAVANAUGH MAUREEN SENIOR VICE PRESIDENT AND CCOO

  • Officer
63,973 2019-07-29 2

FARBER JEFFREY

  • Director
2,134,499 2019-07-19 4

DRABIK DAVID A

  • Director
83,192 2019-07-19 1

TAVEIRA PAUL

  • Director
81,415 2019-07-19 1

CHAPMAN JOHN C

  • Director
46,019 2019-07-19 1

REWOLINSKI MELISSA

  • Director
5,785 2019-07-01 1

MAHER JAMES M.

  • Director
43,492 2018-07-20 0

FARBER DAVID

  • 10% Owner
No longer subject to file 2018-01-16 0

BEDROSIAN ARTHUR P CEO

  • Officer
  • Director
586,038 2017-11-22 0

SMITH KEVIN VP OF SALES AND MARKETING

  • Officer
18,458 2017-11-09 0

ARNOLD KRISTIN VP OF RESEARCH AND DEVELOPMENT

  • Officer
6,068 2017-02-27 0

DEDHIYA MAHENDRA CHIEF SCIENTIFIC AFFAIRS

  • Officer
2,976 2016-07-27 0

SCHRECK WILLIAM CHIEF OPERATING OFFICER

  • Officer
55,379 2015-07-22 0

BOGDA MICHAEL PRESIDENT

  • Officer
3,470 2015-07-22 0

FARBER PROPERTIES GROUP, LLC

  • 10% Owner
0 2015-07-17 0

DESAI ROHIT VP OF NEW PRODUCT STRATEGY

  • Officer
0 2015-06-01 0

SABO ERNEST VP, REGULATORY AND CCO

  • Officer
23,395 2014-12-08 0

SINCLAIR KENNETH

  • Director
41,250 2014-01-22 0

FARBER WILLIAM

  • Director
  • 10% Owner
5,398,423 2013-03-13 0

WEST RONALD A

  • Director
10,000 2012-07-17 0

WINKELMAN MYRON D

  • Director
33,500 2012-07-17 0

WERTHEIMER ALBERT I

  • Director
33,500 2012-07-17 0

RUCK KEITH RICHARD VP - FINANCE AND CFO

  • Officer
6,667 2011-06-14 0

KOVARY STEPHEN JOHN VP - OPERATIONS

  • Officer
0 2009-09-08 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments